(Q39619069)

13 September 2017

title

Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice (English)

1 reference

13 September 2017

author name string

Reginald M Gorczynski

1

1 reference

13 September 2017

David A Clark

2

1 reference

13 September 2017

Nuray Erin

3

1 reference

13 September 2017

Ismat Khatri

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

17 December 2010

1 reference

Breast Cancer Research and Treatment

13 September 2017

published in

1 reference

13 September 2017

volume

130

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

49-60

1 reference

Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Prediction of breast cancer metastasis by genomic profiling: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Effect of pro-inflammatory cytokine stimulation on human breast cancer: implications of chemokine receptor expression in cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Macrophages define the invasive microenvironment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Transforming growth factor beta (TGF-beta) and inflammation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

CD200 is a new prognostic factor in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

CD200 as a prognostic factor in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Targeting cancer stem cells with phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Aurora kinases: shining lights on the therapeutic horizon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Progression and metastasis in a transgenic mouse breast cancer model: effects of exposure to in vivo hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

Concomitant Tumor and Minor Histocompatibility Antigen–Specific Immunity Initiate Rejection and Maintain Remission from Established Spontaneous Solid Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1259-3

10.1007/S10549-010-1259-3

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference